Does family history of alcoholism moderate naltrexone's effects on alcohol use?

Journal of Studies on Alcohol and Drugs

Volumn 72, Issue 1, 2011, Pages 135-140

  Capone, Christy ^a   Kahler, Christopher W ^a   Swift, Robert M ^a   O'Malley, Stephanie S ^a,b  

^a BROWN UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650920008     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2011.72.135     Document Type: Article

References (32)

1. Anton, R. F., O'Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M.,.. for the COMBINE Study Research Group. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. Journal of the American Medical Association, 295, 2003-2017.
2. Boettiger, C. A., Kelley, E. A., Mitchell, J. M., D'Esposito, M., & Fields, H. L. (2009). Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. Pharmacology, Biochemistry, and Behavior, 93, 291-299.
3. Bogenschutz, M. P., Scott Tonigan, J., & Pettinati, H. M. (2009). Effects of alcoholism typology on response to naltrexone in the COMBINE study. Alcoholism: Clinical and Experimental Research, 33, 10-18.
4. COMBINE Study Research Group. (2003). Testing combined pharmaco-therapies and behavioral interventions in alcohol dependence: rationale and methods. Alcoholism: Clinical and Experimental Research, 27, 1107-1122.
5. Drobes, D. J., Anton, R. F., Thomas, S. E., & Voronin, K. (2003). A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: Naltrexone and nalmefene. Neuropsychopharmacology, 28, 755-764.
6. First, M., Spitzer, R., Gibbon, M., & Williams, J. (1996). Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient/Non-patient Edition (SCID-I/P) or (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute, New York.
7. Garbutt, J. C. (2009). The state of pharmacotherapy for the treatment of alcohol dependence. Journal of Substance Abuse Treatment, 36 (Suppl. 1), S15-S23; quiz S24-S25.
8. Garbutt, J. C., Kranzler, H. R., O'Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., et al. for the Vivitrex Study Group. (2005). Ef-ficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial. Journal of the American Medical Association, 293, 1617-1625.
9. Hernandez-Avila, C. A., Song, C., Kuo, L., Tennen, H., Armeli, S., & Kranzler, H. R. (2006). Targeted versus daily naltrexone: Secondary analysis of effects on average daily drinking. Alcoholism: Clinical and Experimental Research, 30, 860-865.
10. Johnson, B. A., Ait-Daoud, N., & Prihoda, T. J. (2000). Combining ondan-setron and naltrexone effectively treats biologically predisposed alcoholics: From hypotheses to preliminary clinical evidence. Alcoholism: Clinical and Experimental Research, 24, 737-742.
11. Kiefer, F., Jiménez-Arriero, M. A., Klein, O., Diehl, A., & Rubio, G. (2008). Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone. Addiction Biology, 13, 124-129.
12. King, A. C., Volpicelli, J. R., Frazer, A., & O'Brien, C. P. (1997). Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology, 129, 15-22.
13. Krishnan-Sarin, S., Krystal, J. H., Shi, J., Pittman, B., & O'Malley, S. S. (2007). Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biological Psychiatry, 62, 694-697.
14. Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A., for the Veterans Affairs Naltrexone Cooperative Study 425 Group. (2001). Naltrexone in the treatment of alcohol dependence. The New England Journal of Medicine, 345, 1734-1739.
15. Miller, W. R. (1996). Form 90: A structured assessment interview for drinking and related behaviors (test manual). NIAAA Project MATCH Monograph Series, Vol. 5, NIH Publication No. 96-4004. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.
16. Miller, W. R. (Ed.) (2004). Combined behavioral intervention manual: A clinical research guide for therapists treating people with alcohol abuse and dependence. NIAAA COMBINE Monograph Series, Vol. 1, DHHS Publication No. (NIH) 04-5288. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.
17. Miller, W. R., Tonigan, J. S., & Longabaugh, R. (1995). The Drinker Inventory of Consequences (DrInC): An instrument for assessing adverse consequences of alcohol abuse (test manual). NIAAA Project MATCH Monograph Series, Vol. 4, NIH Publication No. 95-3911. Bethesda, MD: National Institute of Alcohol Abuse and Alcoholism.
18. Monterosso, J. R., Flannery, B. A., Pettinati, H. M., Oslin, D. W., Rukstalis, M., O'Brien, C. P., & Volpicelli, J. R. (2001). Predicting treatment response to naltrexone: The influence of craving and family history. The American Journal on Addictions, 10, 258-268.
19. Myrick, H., Anton, R. F., Xingbao, L., Henderson, S., Randall, P. K., & Voronin, K. (2008). Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Archives of General Psychiatry, 65, 466-475.
20. O'Malley, S. S., Jaffe, A. J., Chang, G., Schottenfeld, R. S., Meyer, R. E., & Rounsaville, B. (1992). Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry, 49, 881-887.
21. O'Malley, S. S., Krishnan-Sarin, S., Farren, C., Sinha, R., & Kreek, M. J. (2002). Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary- adrenocortical axis. Psychopharmacology, 160, 19-29.
22. O'Malley, S. S., Sinha, R., Grilo, C. M., Capone, C., Farren, C. K., McKee, S. A.,.. Wu, R. (2007). Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: A randomized controlled trial. Alcoholism: Clinical and Experimental Research, 31, 625-634.
23. Pettinati, H. M., Weiss, R. D., Miller, W. R., Donovan, D., Ernst, D. B., & Rounsaville, B. J. (Eds.) (2004). Medical management treatment manual: A clinical research guide for medically trained clinicians providing pharmacotherapy as part of the treatment for alcohol dependence. NIAAA COMBINE Monograph Series, Vol. 2, DHHS Publication No. (NIH) 04-5289. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.
24. Rohsenow, D. J., Miranda, R., Jr., McGeary, J. E., & Monti, P. M. (2007). Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics. Experimental and Clinical Psychophar-macology, 15, 272-281.
25. Rubio, G., Ponce, G., Rodriguez-Jiménez, R., Jiménez- Arriero, M. A., Hoenicka, J., & Palomo, T. (2005). Clinical predictors of response to naltrexone in alcoholic patients: Who benefits most from treatment with naltrexone? Alcohol and Alcoholism, 40, 227-233.
26. Singer, J. D., & Willet, J. B. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York: Oxford University Press.
27. Skinner, H. A., & Allen, B. A. (1982). Alcohol dependence syndrome: Measurement and validation. Journal of Abnormal Psychology, 91, 199-209.
28. Soyka, M., & Rösner, S. (2008). Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review. Current Drug Abuse Reviews, 1, 280-291.
29. Srisurapanont, M., & Jarusuraisin, N. (2005). Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews, Issue 1, Art. No. CD001867.
30. Tidey, J. W., Monti, P. M., Rohsenow, D. J., Gwaltney, C. J., Miranda, R., Jr., McGeary, J. E.,.. Paty, J. A. (2008). Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcoholism: Clinical and Experimental Research, 32, 58-66.
31. Turner, W. M., Cutter, H. S. G., Worobec, T. G., O'Farrell, T. J., Bayog, R. D., & Tsuang, M. T. (1993). Family history models of alcoholism: Age of onset, consequences and dependence. Journal of Studies on Alcohol, 54, 164-171.
32. Volpicelli, J. R., Alterman, A. I., Hayashida, M., & O'Brien, C. P. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49, 876-880.